Stay updated on Maintenance Treatment of Renal Anemia in Dialysis Subjects Clinical Trial
Sign up to get notified when there's something new on the Maintenance Treatment of Renal Anemia in Dialysis Subjects Clinical Trial page.

Latest updates to the Maintenance Treatment of Renal Anemia in Dialysis Subjects Clinical Trial page
- Check6 days agoChange DetectedThe record for a completed Phase 3 study of molidustat versus darbepoetin alfa for renal anemia in dialysis patients is displayed, including its eligibility criteria, study design, locations, and outcome measures.SummaryDifference70%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” was added above the 403 Forbidden message.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page; the error page content remains unchanged.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer’s displayed ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1. The page remains a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing the expected study details with an access-block message. This indicates that the record is not currently accessible, with navigation and footer elements present around the error.SummaryDifference18%

Stay in the know with updates to Maintenance Treatment of Renal Anemia in Dialysis Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maintenance Treatment of Renal Anemia in Dialysis Subjects Clinical Trial page.